Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry

April 16, 2024 updated by: University Medical Center Groningen

Liver Resection and Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry

The purpose of this study is to evaluate the accuracy of continuous SpHb measurement ( Rainbow DCI, Masimo, Irvine Ca, USA) compared to the current method of monitoring (blood sampling), both during phases of hemoconcentration and hemodilution.

Study Overview

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Groningen, Netherlands, 9700RB
        • University Medical Center Groningen,University of Groningen, the Netherlands

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

ASA class I and II patients for elective hepatic resection

Description

Inclusion Criteria:

  • All patients: Age > 18 years
  • ASA class I and II patient requiring hepatic resection

Exclusion Criteria:

  • Patient refusal
  • Patients with a perioperative blood loss exceeding 5ml/kg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1: 15 patients
for elective hepatic resection
Group 2: 15
for elective hepatic resection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To evaluate the accuracy of continuous SpHb measurement during hepatic resection compared with standard (invasive) Hb measurement
Time Frame: during operation
during operation

Secondary Outcome Measures

Outcome Measure
Time Frame
the effect of a bolus of crystalloid on SpHb level will be compared to the effect of a bolus of colloid on the SpHb level.
Time Frame: during operation
during operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Herman G.D. Hendriks, Dr., University Medical Center Groningen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

February 1, 2010

First Submitted That Met QC Criteria

February 1, 2010

First Posted (Estimated)

February 2, 2010

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Hepatic Resection

Clinical Trials on Hemoglobin determination + NaCl 0.9% bolus

3
Subscribe